Corvus Pharmaceuticals, Inc.Corvus Pharmaceuticals, Inc.Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

5.250.00 0.00%
The 2 analysts offering 1 year price forecasts for CRVS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to CRVS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

CRVS EPS for the last quarter is −0.14 USD despite the estimation of −0.12 USD. In the next quarter EPS is expected to reach −0.14 USD. Track more of Corvus Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
According to analysts, CRVS price target is 5.25 USD with a max estimate of 7.00 USD and a min estimate of 3.50 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with CRVS news and stock market news.